228 related articles for article (PubMed ID: 26239619)
1. Induction of microRNA-146a is involved in curcumin-mediated enhancement of temozolomide cytotoxicity against human glioblastoma.
Wu H; Liu Q; Cai T; Chen YD; Wang ZF
Mol Med Rep; 2015 Oct; 12(4):5461-6. PubMed ID: 26239619
[TBL] [Abstract][Full Text] [Related]
2. Growth-inhibitory and chemosensitizing effects of microRNA-31 in human glioblastoma multiforme cells.
Zhou RJ; Xu XY; Liu BX; Dai WZ; Cai MQ; Bai CF; Zhang XF; Wang LM; Lin L; Jia SZ; Wang WH
Int J Mol Med; 2015 Oct; 36(4):1159-64. PubMed ID: 26310668
[TBL] [Abstract][Full Text] [Related]
3. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner.
Wagner L; Marschall V; Karl S; Cristofanon S; Zobel K; Deshayes K; Vucic D; Debatin KM; Fulda S
Oncogene; 2013 Feb; 32(8):988-97. PubMed ID: 22469979
[TBL] [Abstract][Full Text] [Related]
4. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
5. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death.
Chen PH; Cheng CH; Shih CM; Ho KH; Lin CW; Lee CC; Liu AJ; Chang CK; Chen KC
PLoS One; 2016; 11(11):e0167096. PubMed ID: 27893811
[TBL] [Abstract][Full Text] [Related]
6. Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways.
Bagherian A; Mardani R; Roudi B; Taghizadeh M; Banfshe HR; Ghaderi A; Davoodvandi A; Shamollaghamsari S; Hamblin MR; Mirzaei H
J Mol Neurosci; 2020 Oct; 70(10):1471-1483. PubMed ID: 32666415
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Anti-Cancer Effects of Icariin and Temozolomide in Glioblastoma.
Yang L; Wang Y; Guo H; Guo M
Cell Biochem Biophys; 2015 Apr; 71(3):1379-85. PubMed ID: 25384619
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with micellarized cyclopamine and temozolomide attenuate glioblastoma growth through Gli1 down-regulation.
Liu YJ; Ma YC; Zhang WJ; Yang ZZ; Liang DS; Wu ZF; Qi XR
Oncotarget; 2017 Jun; 8(26):42495-42509. PubMed ID: 28477008
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-326 sensitizes human glioblastoma cells to curcumin via the SHH/GLI1 signaling pathway.
Yin S; Du W; Wang F; Han B; Cui Y; Yang D; Chen H; Liu D; Liu X; Zhai X; Jiang C
Cancer Biol Ther; 2018 Apr; 19(4):260-270. PubMed ID: 27819521
[TBL] [Abstract][Full Text] [Related]
10. miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas.
Haemmig S; Baumgartner U; Glück A; Zbinden S; Tschan MP; Kappeler A; Mariani L; Vajtai I; Vassella E
Cell Death Dis; 2014 Jun; 5(6):e1279. PubMed ID: 24901050
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-κB-dependent pathway.
Huang H; Lin H; Zhang X; Li J
Oncol Rep; 2012 Jun; 27(6):2050-6. PubMed ID: 22426504
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of etoposide and temozolomide cytotoxicity by curcumin and turmeric force™ in brain tumor cell lines.
Ramachandran C; Nair SM; Escalon E; Melnick SJ
J Complement Integr Med; 2012 Aug; 9():Article 20. PubMed ID: 22944718
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of CDC2 expression inhibits proliferation, enhances apoptosis, and increases chemosensitivity to temozolomide in glioblastoma cells.
Zhou B; Bu G; Zhou Y; Zhao Y; Li W; Li M
Med Oncol; 2015 Jan; 32(1):378. PubMed ID: 25433945
[TBL] [Abstract][Full Text] [Related]
14. Triptolide synergistically enhances temozolomide-induced apoptosis and potentiates inhibition of NF-κB signaling in glioma initiating cells.
Sai K; Li WY; Chen YS; Wang J; Guan S; Yang QY; Guo CC; Mou YG; Li WP; Chen ZP
Am J Chin Med; 2014; 42(2):485-503. PubMed ID: 24707876
[TBL] [Abstract][Full Text] [Related]
15. Curcumin sensitizes glioblastoma to temozolomide by simultaneously generating ROS and disrupting AKT/mTOR signaling.
Yin H; Zhou Y; Wen C; Zhou C; Zhang W; Hu X; Wang L; You C; Shao J
Oncol Rep; 2014 Oct; 32(4):1610-6. PubMed ID: 25050915
[TBL] [Abstract][Full Text] [Related]
16. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway.
Jin H; Qiao F; Wang Y; Xu Y; Shang Y
Oncol Rep; 2015 Nov; 34(5):2782-9. PubMed ID: 26351877
[TBL] [Abstract][Full Text] [Related]
17. Characterizing the molecular mechanisms of acquired temozolomide resistance in the U251 glioblastoma cell line by protein microarray.
Lin J; Zuo J; Cui Y; Song C; Wu X; Feng H; Li J; Li S; Xu Q; Wei W; Qiu G; He H
Oncol Rep; 2018 May; 39(5):2333-2341. PubMed ID: 29565460
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis.
Shi L; Zhang S; Feng K; Wu F; Wan Y; Wang Z; Zhang J; Wang Y; Yan W; Fu Z; You Y
Int J Oncol; 2012 Jan; 40(1):119-29. PubMed ID: 21879257
[TBL] [Abstract][Full Text] [Related]
19. Induction of microRNA-9 mediates cytotoxicity of curcumin against SKOV3 ovarian cancer cells.
Zhao SF; Zhang X; Zhang XJ; Shi XQ; Yu ZJ; Kan QC
Asian Pac J Cancer Prev; 2014; 15(8):3363-8. PubMed ID: 24870723
[TBL] [Abstract][Full Text] [Related]
20. Autophagy inhibition improves the efficacy of curcumin/temozolomide combination therapy in glioblastomas.
Zanotto-Filho A; Braganhol E; Klafke K; Figueiró F; Terra SR; Paludo FJ; Morrone M; Bristot IJ; Battastini AM; Forcelini CM; Bishop AJR; Gelain DP; Moreira JCF
Cancer Lett; 2015 Mar; 358(2):220-231. PubMed ID: 25542083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
